Protein-based molecular imprinting: gelatin nanotraps for interleukin-6 sequestration in inflammation cell models

Gelatin methacryloyl (GelMA) was harnessed to create nanotraps via molecular imprinting that were specifically designed to scavenge interleukin-6 (IL-6) in inflammation models. This innovative approach leverages safe and biocompatible protein-based biomaterials, paving the way for a novel class of therapeutic solutions with significant clinical potential.